Form 4 for EFX Equifax
Accepted 2024-08-01 00:00:00 ET · period of report 2024-07-30 · accession 0001225208-24-007766 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-01 | 2024-07-30 | EFX | GAMBLE JOHN W JR | EVP, CFO, COO | S - Sale+OE | $276.49 | -1,350 | 61.5K | -2% | -$373.3K |
| DM | 2024-08-01 | 2024-07-31 | EFX | GAMBLE JOHN W JR | EVP, CFO, COO | M - OptEx | $184.38 | +18.6K | 79.4K | +31% | +$3.42M |
| D | 2024-08-01 | 2024-07-31 | EFX | GAMBLE JOHN W JR | EVP, CFO, COO | F - Tax | $278.27 | -15.1K | 64.3K | -19% | -$4.21M |
| DM | 2024-08-01 | 2024-07-31 | EFX | GAMBLE JOHN W JR | EVP, CFO, COO | M - OptEx | $0.00 | -18.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-30 | S | D | 601 | $276.39 | 60,849 | D | — | — | (F5) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $276.05 to $276.99, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 2 | Common | Common Stock | 2024-07-31 | M | A | 10,355 | $191.44 | 71,204 | D | — | — | (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 3 | Common | Common Stock | 2024-07-31 | F | D | 15,125 | $278.27 | 64,287 | D | — | — | (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 4 | Common | Common Stock | 2024-07-31 | M | A | 8,208 | $175.48 | 79,412 | D | — | — | (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 5 | Common | Common Stock | 2024-07-30 | S | D | 87 | $279.29 | 62,112 | D | — | — | (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 6 | Common | Common Stock | 2024-07-30 | S | D | 317 | $277.18 | 61,795 | D | — | — | (F3) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $277.14 to $277.305, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 7 | Common | Common Stock | 2024-07-30 | S | D | 345 | $275.31 | 61,450 | D | — | — | (F4) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $274.84 to $275.64, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 8 | Derivative | Stock Option/Right to Buy | 2024-07-31 | M | D | 10,355 | $0.00 | 0 | D | $191.44 · — to 2026-02-21 | 10,355 Common Stock | (F6) The option vested in three equal annual increments beginning 2/21/2021. |
| 9 | Derivative | Stock Option/Right to Buy | 2024-07-31 | M | D | 8,208 | $0.00 | 0 | D | $175.48 · — to 2026-02-21 | 8,208 Common Stock | (F6) The option vested in three equal annual increments beginning 2/21/2021. |